Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Combined Ketorolac and Lidocaine Paracervical Block for Office Hysteroscopy
NCT06653400Phase 1Enrolling by invitation
- Sponsor
- Icahn School of Medicine at Mount Sinai
- Start
- Jul 2026
- Primary completion
- Dec 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of ketorolac in pain (2 arms), sponsored by Icahn School of Medicine at Mount Sinai. Primary endpoint: Pain Visual Analogue Scale. Started Jul 2026; status: enrolling by invitation.
02
Drugs
ketorolac
03
Conditions
pain
Beyond the preview
Go deeper on NCT06653400.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06653400.